Pratima Nangia‐Makker

6.0k total citations
72 papers, 4.7k citations indexed

About

Pratima Nangia‐Makker is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Pratima Nangia‐Makker has authored 72 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 43 papers in Immunology and 27 papers in Oncology. Recurrent topics in Pratima Nangia‐Makker's work include Galectins and Cancer Biology (40 papers), Signaling Pathways in Disease (20 papers) and Peptidase Inhibition and Analysis (14 papers). Pratima Nangia‐Makker is often cited by papers focused on Galectins and Cancer Biology (40 papers), Signaling Pathways in Disease (20 papers) and Peptidase Inhibition and Analysis (14 papers). Pratima Nangia‐Makker collaborates with scholars based in United States, Japan and China. Pratima Nangia‐Makker's co-authors include Avraham Raz, Victor Hogan, Yuichiro Honjo, Vitaly Balan, Larry Tait, Shiro Akahani, Adhip P.N. Majumdar, Abbasali Raz, Yingjie Yu and Lulu Farhana and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and PLoS ONE.

In The Last Decade

Pratima Nangia‐Makker

72 papers receiving 4.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pratima Nangia‐Makker United States 37 3.1k 2.8k 1.2k 622 334 72 4.7k
Victor Hogan United States 37 2.8k 0.9× 2.7k 1.0× 933 0.8× 410 0.7× 384 1.1× 53 4.4k
Larry Tait United States 29 2.1k 0.7× 976 0.4× 1.2k 1.0× 743 1.2× 296 0.9× 55 3.6k
Lu‐Gang Yu United Kingdom 35 2.5k 0.8× 2.0k 0.7× 616 0.5× 203 0.3× 161 0.5× 102 3.7k
Mitsuo Katano Japan 44 2.9k 0.9× 1.3k 0.5× 2.1k 1.7× 1.0k 1.6× 322 1.0× 157 5.5k
Pedro Miguel Lacal Italy 35 2.3k 0.8× 622 0.2× 1.4k 1.2× 595 1.0× 129 0.4× 101 3.8k
Rehan Ahmad United States 37 2.4k 0.8× 734 0.3× 1.0k 0.9× 675 1.1× 103 0.3× 84 3.7k
Patrick J. Duriez United Kingdom 28 1.9k 0.6× 1.3k 0.5× 694 0.6× 255 0.4× 79 0.2× 53 3.5k
Carl L. Manthey United States 30 1.6k 0.5× 1.1k 0.4× 800 0.7× 476 0.8× 75 0.2× 58 3.3k
Mei Huang China 33 2.5k 0.8× 1.6k 0.6× 2.6k 2.2× 677 1.1× 200 0.6× 88 5.4k
Qian Mei China 29 1.6k 0.5× 827 0.3× 792 0.7× 888 1.4× 100 0.3× 68 3.0k

Countries citing papers authored by Pratima Nangia‐Makker

Since Specialization
Citations

This map shows the geographic impact of Pratima Nangia‐Makker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pratima Nangia‐Makker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pratima Nangia‐Makker more than expected).

Fields of papers citing papers by Pratima Nangia‐Makker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pratima Nangia‐Makker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pratima Nangia‐Makker. The network helps show where Pratima Nangia‐Makker may publish in the future.

Co-authorship network of co-authors of Pratima Nangia‐Makker

This figure shows the co-authorship network connecting the top 25 collaborators of Pratima Nangia‐Makker. A scholar is included among the top collaborators of Pratima Nangia‐Makker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pratima Nangia‐Makker. Pratima Nangia‐Makker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nangia‐Makker, Pratima, Victor Hogan, Vitaly Balan, & Avraham Raz. (2022). Chimeric galectin-3 and collagens: Biomarkers and potential therapeutic targets in fibroproliferative diseases. Journal of Biological Chemistry. 298(12). 102622–102622. 18 indexed citations
2.
Genovese, Salvatore, Francesco Epifano, Francesca Preziuso, et al.. (2019). Gercumin synergizes the action of 5-fluorouracil and oxaliplatin against chemoresistant human cancer colon cells. Biochemical and Biophysical Research Communications. 522(1). 95–99. 10 indexed citations
3.
Saadat, Nadia, Fangchao Liu, Brittany Haynes, et al.. (2018). Nano-delivery of RAD6 /Translesion Synthesis Inhibitor SMI#9 for Triple-negative Breast Cancer Therapy. Molecular Cancer Therapeutics. 17(12). 2586–2597. 15 indexed citations
4.
Haynes, Brittany, et al.. (2017). Breast cancer complexity: implications of intratumoral heterogeneity in clinical management. Cancer and Metastasis Reviews. 36(3). 547–555. 60 indexed citations
5.
Farhana, Lulu, Fadi Antaki, Pratima Nangia‐Makker, et al.. (2016). Role of cancer stem cells in racial disparity in colorectal cancer. Cancer Medicine. 5(6). 1268–1278. 34 indexed citations
6.
Nangia‐Makker, Pratima, et al.. (2014). Metformin: A Potential Therapeutic Agent for Recurrent Colon Cancer. PLoS ONE. 9(1). e84369–e84369. 102 indexed citations
7.
Sanders, Matthew A., Pratima Nangia‐Makker, Vitaly Balan, et al.. (2013). Novel Inhibitors of Rad6 Ubiquitin Conjugating Enzyme: Design, Synthesis, Identification, and Functional Characterization. Molecular Cancer Therapeutics. 12(4). 373–383. 53 indexed citations
8.
Shekhar, Malathy P.V., Ikuko Kato, Pratima Nangia‐Makker, & Larry Tait. (2013). Comedo-DCIS is a precursor lesion for basal-like breast carcinoma: identification of a novel p63/Her2/neu expressing subgroup. Oncotarget. 4(2). 231–241. 18 indexed citations
9.
Balan, Vitaly, Yi Wang, Pratima Nangia‐Makker, et al.. (2013). Galectin-3: a possible complementary marker to the PSA blood test. Oncotarget. 4(4). 542–549. 47 indexed citations
10.
Kho, Dhong Hyo, Pratima Nangia‐Makker, Vitaly Balan, et al.. (2012). Autocrine Motility Factor Promotes HER2 Cleavage and Signaling in Breast Cancer Cells. Cancer Research. 73(4). 1411–1419. 32 indexed citations
11.
Wang, Ying, et al.. (2012). Galectin-3 regulates p21 stability in human prostate cancer cells. Oncogene. 32(42). 5058–5065. 20 indexed citations
12.
Nangia‐Makker, Pratima, Yi Wang, Tirza Raz, et al.. (2010). Cleavage of galectin‐3 by matrix metalloproteases induces angiogenesis in breast cancer. International Journal of Cancer. 127(11). 2530–2541. 89 indexed citations
13.
Balan, Vitaly, Pratima Nangia‐Makker, Ann G. Schwartz, et al.. (2008). Racial Disparity in Breast Cancer and Functional Germ Line Mutation in Galectin-3 (rs4644): A Pilot Study. Cancer Research. 68(24). 10045–10050. 49 indexed citations
14.
Nangia‐Makker, Pratima, Vitaly Balan, & Avraham Raz. (2008). Regulation of Tumor Progression by Extracellular Galectin-3. Cancer Microenvironment. 1(1). 43–51. 100 indexed citations
15.
Shekhar, Malathy P.V., Larry Tait, Robert J. Pauley, et al.. (2008). Comedo-Ductal carcinoma in situ: A paradoxical role for programmed cell death. Cancer Biology & Therapy. 7(11). 1774–1782. 27 indexed citations
16.
Nangia‐Makker, Pratima, Larry Tait, Victor Hogan, Frederick W. Miller, & Avraham Raz. (2006). Inhibition of breast cancer progression by a medicinal herb Ocimum sanctum. Cancer Research. 66. 513–513. 2 indexed citations
17.
Mazurek, Nachman, Janet E. Price, Latha Ramdas, et al.. (2005). Phosphorylation of Galectin-3 Contributes to Malignant Transformation of Human Epithelial Cells via Modulation of Unique Sets of Genes. Cancer Research. 65(23). 10767–10775. 39 indexed citations
18.
Nangia‐Makker, Pratima, Larry Tait, Victor Hogan, & Avraham Raz. (2004). Inhibition of angiogenesis by a common herb: Ocimum sactum. Cancer Research. 64. 949–949. 1 indexed citations
19.
Nangia‐Makker, Pratima, et al.. (2000). Carbohydrate-Recognition and Angiogenesis. Cancer and Metastasis Reviews. 19(1-2). 51–57. 33 indexed citations
20.
Akahani, Shiro, Hidenori Inohara, Pratima Nangia‐Makker, & Avraham Raz. (1997). Galectin-3 in Tumor Metastasis.. Trends in Glycoscience and Glycotechnology. 9(45). 69–75. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Victor Hogan Breakdown of academic impact, for papers by Larry Tait Breakdown of academic impact, for papers by Lu‐Gang Yu Breakdown of academic impact, for papers by Mitsuo Katano Breakdown of academic impact, for papers by Pedro Miguel Lacal Breakdown of academic impact, for papers by Rehan Ahmad Breakdown of academic impact, for papers by Patrick J. Duriez Breakdown of academic impact, for papers by Carl L. Manthey Breakdown of academic impact, for papers by Mei Huang Breakdown of academic impact, for papers by Qian Mei
Rankless by CCL
2026